{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2019-N-5711\" and posted_year = 2020 sorted by posted_date descending", "rows": [["FDA-2019-N-5711-1260", "FDA", "FDA-2019-N-5711", "RIA_REF1 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:21:16Z", null, 0, 0, "09000064848762d8"], ["FDA-2019-N-5711-1267", "FDA", "FDA-2019-N-5711", "RIA_REF8 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:22:16Z", null, 0, 0, "09000064848765cd"], ["FDA-2019-N-5711-1257", "FDA", "FDA-2019-N-5711", "Final rule ref 04 Government of Canada, Consultation Regulations Amending the Food and Drug Regulations 1447-Good Manufacturing Practices", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:17:55Z", null, 0, 0, "090000648486ac43"], ["FDA-2019-N-5711-1263", "FDA", "FDA-2019-N-5711", "RIA_REF4 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:21:43Z", null, 0, 0, "09000064848765c9"], ["FDA-2019-N-5711-1258", "FDA", "FDA-2019-N-5711", "Final rule ref 05 Government of Canada, Health Canada, GMP Drug Establishment Good Manufacturing Practices Pre-Application Package Importers, Distributors and Wholesalers", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:18:17Z", null, 0, 0, "090000648486ac44"], ["FDA-2019-N-5711-1265", "FDA", "FDA-2019-N-5711", "RIA_REF6 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:22:01Z", null, 0, 0, "09000064848765cb"], ["FDA-2019-N-5711-1259", "FDA", "FDA-2019-N-5711", "Final rule ref 06 Final Regulatory Impact Analysis", "Other", "Additional Information", "2020-11-24T05:00:00Z", 2020, 11, "2020-11-24T05:00:00Z", null, "2020-11-24T17:18:51Z", null, 0, 0, "09000064848762d6"], ["FDA-2019-N-5711-1256", "FDA", "FDA-2019-N-5711", "Final rule ref 03 HHS Report on Prescription Drug Importation", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:17:30Z", null, 0, 0, "090000648486ac42"], ["FDA-2019-N-5711-1262", "FDA", "FDA-2019-N-5711", "RIA_REF3 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:21:35Z", null, 0, 0, "09000064848762da"], ["FDA-2019-N-5711-1268", "FDA", "FDA-2019-N-5711", "RIA_REF9 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:22:25Z", null, 0, 0, "09000064848765ce"], ["FDA-2019-N-5711-1266", "FDA", "FDA-2019-N-5711", "RIA_REF7 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:22:09Z", null, 0, 0, "09000064848765cc"], ["FDA-2019-N-5711-1255", "FDA", "FDA-2019-N-5711", "Final rule ref 02 Internet Pharmacy Warning Letters _ FDA", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:17:09Z", null, 0, 0, "090000648486ac41"], ["FDA-2019-N-5711-1264", "FDA", "FDA-2019-N-5711", "RIA_REF5 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:21:51Z", null, 0, 0, "09000064848765ca"], ["FDA-2019-N-5711-1254", "FDA", "FDA-2019-N-5711", "Final rule ref 01 FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids _ FDA", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:16:47Z", null, 0, 0, "09000064848693a0"], ["FDA-2019-N-5711-1261", "FDA", "FDA-2019-N-5711", "RIA_REF2 RE Final rule ref 06 Final Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2020-11-24T05:00:00Z", 2020, 11, null, null, "2020-11-24T17:21:26Z", null, 0, 0, "09000064848762d9"], ["FDA-2019-N-5711-1253", "FDA", "FDA-2019-N-5711", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2020-11-12T05:00:00Z", 2020, 11, "2020-11-12T05:00:00Z", null, "2023-03-29T14:23:00Z", "2020-25019", 0, 0, "090000648495a209"], ["FDA-2019-N-5711-1252", "FDA", "FDA-2019-N-5711", "Importation of Prescription Drugs", "Rule", "Final Rule", "2020-10-01T04:00:00Z", 2020, 10, "2020-10-01T04:00:00Z", null, "2020-10-01T14:54:00Z", "2020-21522", 0, 0, "09000064848abb2b"], ["FDA-2019-N-5711-0012", "FDA", "FDA-2019-N-5711", "Ref. 09. Iuga and McGuire 2014 Adherence and Health Care Costs Risk Management and Healthcare Policy re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:46Z", null, 0, 0, "090000648420d86e"], ["FDA-2019-N-5711-0028", "FDA", "FDA-2019-N-5711", "Ref. 25. Ashley 2017 Letter to the Editor The Price of Crossing the Border for Medications NEJM re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:07Z", null, 0, 0, "090000648420d886"], ["FDA-2019-N-5711-0037", "FDA", "FDA-2019-N-5711", "Reference 4 Medicine Use and Spending in the US A Review of 2018 and Outlook to 2023 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:18Z", null, 0, 0, "090000648420d89b"], ["FDA-2019-N-5711-0035", "FDA", "FDA-2019-N-5711", "Reference 2 Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:02Z", null, 0, 0, "090000648420d899"], ["FDA-2019-N-5711-0005", "FDA", "FDA-2019-N-5711", "Ref. 02. Mark McClellan FDA Commissioner 2003 Letter to Senator Thad Cochran re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:41:49Z", null, 0, 0, "090000648420d83d"], ["FDA-2019-N-5711-0026", "FDA", "FDA-2019-N-5711", "Ref. 23. FDA 2012 Warning Letter to Canadadrugs re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:51Z", null, 0, 0, "090000648420d883"], ["FDA-2019-N-5711-0034", "FDA", "FDA-2019-N-5711", "Reference 1 - Commercial Importation of Prescription Drugs in the United States Short-Run Implications Re: Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:55Z", null, 0, 0, "090000648420d898"], ["FDA-2019-N-5711-0036", "FDA", "FDA-2019-N-5711", "Reference 3 International Prices And Availability Of Pharmaceuticals In 2005 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:09Z", null, 0, 0, "090000648420d89a"], ["FDA-2019-N-5711-0010", "FDA", "FDA-2019-N-5711", "Ref. 07. HHS 2016 ASPE Issue Brief Observations on Trends in Prescription Drug Spending re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:30Z", null, 0, 0, "090000648420d86c"], ["FDA-2019-N-5711-0039", "FDA", "FDA-2019-N-5711", "Reference 6 Pharmaceutical trends Retail Prescriptions Dispensed in Canada, 2014-2018 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:34Z", null, 0, 0, "090000648420d8a0"], ["FDA-2019-N-5711-0015", "FDA", "FDA-2019-N-5711", "Ref. 12. John Thomas 2016 Congressional Research Service Patents and Prescription Drug Importation re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:43:23Z", null, 0, 0, "090000648420d871"], ["FDA-2019-N-5711-0017", "FDA", "FDA-2019-N-5711", "Ref. 14. Gagnon and Wolfe 2015 Mirror Mirror on the Wall Medicare Part D re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:43:39Z", null, 0, 0, "090000648420d873"], ["FDA-2019-N-5711-0018", "FDA", "FDA-2019-N-5711", "Ref. 15. PMPRB Annual Report 2017 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:43:47Z", null, 0, 0, "090000648420d87a"], ["FDA-2019-N-5711-0022", "FDA", "FDA-2019-N-5711", "Ref. 19. FDA 2018 Global Operation re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:21Z", null, 0, 0, "090000648420d87f"], ["FDA-2019-N-5711-0040", "FDA", "FDA-2019-N-5711", "Reference 7 Preliminary Estimate - S. 469, the Affordable and Safe Prescription Drug Importation Act (as introduced) re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:42Z", null, 0, 0, "090000648420d8a1"], ["FDA-2019-N-5711-0031", "FDA", "FDA-2019-N-5711", "Ref. 28. Health Canada 2019 Joint Public Consultation on ICH Guidelines Update re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:31Z", null, 0, 0, "090000648420d889"], ["FDA-2019-N-5711-0033", "FDA", "FDA-2019-N-5711", "Ref. 30. ASTM E122-17 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:47Z", null, 0, 0, "090000648420d88b"], ["FDA-2019-N-5711-0009", "FDA", "FDA-2019-N-5711", "Ref. 06. GAO-18-40 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:22Z", null, 0, 0, "090000648420d86b"], ["FDA-2019-N-5711-0023", "FDA", "FDA-2019-N-5711", "Ref. 20. DOJ 2017 Millions of Medicines Seized in Largest INTERPOL Operation Against Illicit Online Pharmacies re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:28Z", null, 0, 0, "090000648420d880"], ["FDA-2019-N-5711-0032", "FDA", "FDA-2019-N-5711", "Ref. 29. Joanne Eglovitch 2019 GS1 Standard Would Speed the Sale of Returned Drugs After November Deadline Pink Sheet re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:39Z", null, 0, 0, "090000648420d88a"], ["FDA-2019-N-5711-0038", "FDA", "FDA-2019-N-5711", "Reference 5 Patented Medicine Prices Review Board Annual Report 2017 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:27Z", null, 0, 0, "090000648420d89f"], ["FDA-2019-N-5711-0042", "FDA", "FDA-2019-N-5711", "Reference 9 Would Prescription Drug Importation Reduce U.S. Drug Spending re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:47:00Z", null, 0, 0, "090000648420d8a3"], ["FDA-2019-N-5711-0004", "FDA", "FDA-2019-N-5711", "Ref. 01. Donna Shalala Secretary of Health and Human Services 2000 Letter to President Clinton re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:41:27Z", null, 0, 0, "090000648420d83c"], ["FDA-2019-N-5711-0016", "FDA", "FDA-2019-N-5711", "Ref. 13. Ben Hirschler 2015 How the US Pays 3 Times More for Drugs Scientific American re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:43:31Z", null, 0, 0, "090000648420d872"], ["FDA-2019-N-5711-0041", "FDA", "FDA-2019-N-5711", "Reference 8 Report on Prescription Drug Importation re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:50Z", null, 0, 0, "090000648420d8a2"], ["FDA-2019-N-5711-0008", "FDA", "FDA-2019-N-5711", "Ref. 05. HHS Task Force on Drug Importation 2004 Report on Prescription Drug Importation re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:14Z", null, 0, 0, "090000648420d86a"], ["FDA-2019-N-5711-0011", "FDA", "FDA-2019-N-5711", "Ref. 08. KFF Health Tracking Poll February 2019 Prescription Drugs re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:38Z", null, 0, 0, "090000648420d86d"], ["FDA-2019-N-5711-0021", "FDA", "FDA-2019-N-5711", "Ref. 18. KFF Health Tracking Poll November 2016 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:09Z", null, 0, 0, "090000648420d87e"], ["FDA-2019-N-5711-0013", "FDA", "FDA-2019-N-5711", "Ref. 10. Jonel Aleccia 2019 Lawmakers Advocates NPR re Importation of Prescription Drugs re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:53Z", null, 0, 0, "090000648420d86f"], ["FDA-2019-N-5711-0029", "FDA", "FDA-2019-N-5711", "Ref. 26. Canada Consultation Regulations Amending the Food and Drug Regulations 1447 Good Manufacturing Practices re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:15Z", null, 0, 0, "090000648420d887"], ["FDA-2019-N-5711-0006", "FDA", "FDA-2019-N-5711", "Ref. 03. Randall Lutter Acting Associate Commissioner for Policy and Planning 2005 Letter to Theodore Kulongoski re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:41:58Z", null, 0, 0, "090000648420d83e"], ["FDA-2019-N-5711-0027", "FDA", "FDA-2019-N-5711", "Ref. 24. FDA 2005 FDA Operation Reveals Many Drugs Promoted as Canadian Products Really Originate From Other Countries re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:59Z", null, 0, 0, "090000648420d885"], ["FDA-2019-N-5711-0007", "FDA", "FDA-2019-N-5711", "Ref. 04. Nomination of Robert Califf to Serve as FDA Commissioner 2015 re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:42:06Z", null, 0, 0, "090000648420d83f"], ["FDA-2019-N-5711-0024", "FDA", "FDA-2019-N-5711", "Ref. 21. DOJ 2013 Paul Daniel Bottomley Pleads Guilty in US Federal Court re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:36Z", null, 0, 0, "090000648420d881"], ["FDA-2019-N-5711-0014", "FDA", "FDA-2019-N-5711", "Ref. 11. Liz Szabo 2017 As Drug Costs Soar People Delay or Skip Cancer Treatments National Public Radio re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:43:01Z", null, 0, 0, "090000648420d870"], ["FDA-2019-N-5711-0019", "FDA", "FDA-2019-N-5711", "Ref. 16. PMPRB Mandate and Jurisdiction re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:43:53Z", null, 0, 0, "090000648420d87c"], ["FDA-2019-N-5711-0020", "FDA", "FDA-2019-N-5711", "Ref. 17. Rachel Bluth 2016 Faced with Unaffordable Drug Prices Tens of Millions Buy Medicine Outside US Kaiser Health News re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:01Z", null, 0, 0, "090000648420d87d"], ["FDA-2019-N-5711-0025", "FDA", "FDA-2019-N-5711", "Ref. 22. DOJ 2018 Canadian Drug Firm re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:44:43Z", null, 0, 0, "090000648420d882"], ["FDA-2019-N-5711-0030", "FDA", "FDA-2019-N-5711", "Ref. 27. Health Canada GMP Drug Establishment re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:45:23Z", null, 0, 0, "090000648420d888"]], "truncated": false, "filtered_table_rows_count": 56, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2019-N-5711", "p1": "2020"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020", "results": [{"value": "FDA", "label": "FDA", "count": 56, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 53, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020", "results": [{"value": 2020, "label": 2020, "count": 56, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2019-N-5711&posted_year=2020&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1029.7452310333028, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}